XENE

Xenon Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↓ 1/10
  • Value↑ 6/10
Xenon Pharmaceuticals sales and earnings growth
XENE Growth
Low
  • Revenue Y/Y↓ -100.00%
  • EPS Y/Y↓ -45.51%
  • FCF Y/Y↓ -53.79%
Xenon Pharmaceuticals gross and profit margin trends
XENE Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -39.53%
Xenon Pharmaceuticals net debt vs free cash flow
XENE Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Xenon Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks